AVX-470, an Orally Delivered Anti-TNF Antibody for Treatment of Acute Ulcerative Colitis: Results of a First-inHuman Trial M Scott Harris1, Deborah Hartman1, Sharon Spence1, Sally Kennedy1, Theodore Ptak2, Ronald Pruitt3

First Page		Document Content
Date: 2014-10-22 17:54:16 Immunology Biotechnology Immune system Autoimmune diseases Monoclonal antibodies TNF inhibitor Ulcerative colitis Biologic Infliximab Medicine Anatomy Health		AVX-470, an Orally Delivered Anti-TNF Antibody for Treatment of Acute Ulcerative Colitis: Results of a First-inHuman Trial M Scott Harris1, Deborah Hartman1, Sharon Spence1, Sally Kennedy1, Theodore Ptak2, Ronald Pruitt3 Add to Reading List Source URL: www.avaxiabiologics.com Download Document from Source Website File Size: 421,92 KB Share Document on Facebook

	SCIENCE AND FIBROMYALGIA A Review of Recent Research for Fibromyalgia Awareness Day, May 12, 1999 In February of this year, an article in a scientific journal announced the discovery that a new immune system antibody had DocID: 1vs8m - View Document
	Reprogramming the Immune System for the Establishment of ToleranceIntegrating European research on immune tolerance: a key step to build a better future for transplanted patients. DocID: 1vrpL - View Document
	4 Original Article Computational Ensemble Approach for Immune System Study: Conformational B-cell Epitope Prediction DocID: 1vinS - View Document
	THE CANCER REVOLUTION Additional Material for Appendix 1 Francisco Contreras, MD and Daniel Kennedy Contreras Dendritic cell cancer vaccine The most powerful anti-cancer agent is the immune system. In fact, it’s imposs DocID: 1vfY6 - View Document
	Applications of Immune System Computing Ricardo Hoar What kind of applications? DocID: 1vaZn - View Document